Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry.
Koch KT, Grundeken MJ, Vos NS, IJsselmuiden AJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JG, Amoroso G. Koch KT, et al. Among authors: vos ns. EuroIntervention. 2015 Jul;11(3):264-71. doi: 10.4244/EIJY15M02_08. EuroIntervention. 2015. PMID: 25692610 Free article. Clinical Trial.
A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: the International MGuard Prime Observational Study (IMOS Prime).
Amoroso G, Vos NS, Van der Heyden JA, van der Schaaf RJ, Patterson MS, Vink MA, Herrman JP, Slagboom T. Amoroso G, et al. Among authors: vos ns. Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S28-33. doi: 10.1002/ccd.25914. Epub 2015 Mar 24. Catheter Cardiovasc Interv. 2015. PMID: 25754236
Pre-hospital management, procedural performance and outcomes for primary percutaneous coronary intervention in ST-elevation myocardial infarction in the Netherlands: Insights from the Dutch cohort of the APPOSITION-III trial.
Vos NS, Amoroso G, Grundeken MJ, Ijsselmuiden AJ, van Geuns RJ, Spaargaren R, Tijssen JG, Koch KT. Vos NS, et al. Neth Heart J. 2016 Dec;24(12):730-739. doi: 10.1007/s12471-016-0891-x. Epub 2016 Aug 31. Neth Heart J. 2016. PMID: 27580741 Free PMC article.
Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
Lu H, Grundeken MJ, Vos NS, IJsselmuiden AJJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JGP, Amoroso G, de Winter RJ, Koch KT. Lu H, et al. Among authors: vos ns. EuroIntervention. 2017 Aug 4;13(5):e572-e577. doi: 10.4244/EIJ-D-16-00676. EuroIntervention. 2017. PMID: 28191875 Free article. Clinical Trial.
One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
Grundeken MJ, Lu H, Vos N, IJsselmuiden A, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JGP, de Winter RJ, Wykrzykowska JJ, Amoroso G, Koch KT. Grundeken MJ, et al. J Invasive Cardiol. 2017 Aug;29(8):253-258. J Invasive Cardiol. 2017. PMID: 28756418 Free article.
18 results